in London announced it would review drugs similar to Vioxx .
By contrast , Vioxx made $ 2.5 billion for Merck last year .
Merck & Co. removed Vioxx after new study results showed increased risk of heart attacks and stroke who used it for longer than 18 months .
In a report Dr. Eric Topol of the Cleveland Clinic chastises the FDA for not requiring Merck to do studies investigating heart problems with Vioxx when hints of them first appeared years ago .
`` This Merck is announcing a voluntary worldwide withdrawal of Vioxx , '' Gilmartin began .
